Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroki Yokoo

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Journal of Pharmacological Sciences|November 24, 2004
Molecular mechanisms and drug development in aquaporin water channel diseases: aquaporins in the brainHideyuki Kobayashi, Toshihiko Yanagita, Hiroki Yokoo, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|June 14, 2002
[Regulation of brain microvessel function]Hideyuki Kobayashi, Hiroki Yokoo, Toshihiko Yanagita, et al.
Journal of Pharmacological Sciences|December 13, 2005
Lithium: potential therapeutics against acute brain injuries and chronic neurodegenerative diseasesAkihiko Wada, Hiroki Yokoo, Toshihiko Yanagita, et al.
Frontiers in Bioscience : a Journal and Virtual Library|February 24, 2004
Regulation of cell surface expression of voltage-dependent Nav1.7 sodium channels: mRNA stability and posttranscriptional control in adrenal chromaffin cellsAkihiko Wada, Toshihiko Yanagita, Hiroki Yokoo, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 13, 2003
Pathophysiological function of adrenomedullin and proadrenomedullin N-terminal peptides in adrenal chromaffin cellsHideyuki Kobayashi, Toshihiko Yanagita, Hiroki Yokoo, et al.
Journal of Pharmacological Sciences|October 8, 2005
New twist on neuronal insulin receptor signaling in health, disease, and therapeuticsAkihiko Wada, Hiroki Yokoo, Toshihiko Yanagita, et al.
Critical Care Medicine|August 27, 2009
Nuclear factor-kappaB decoy oligodeoxynucleotides ameliorate impaired glucose tolerance and insulin resistance in mice with cecal ligation and puncture-induced sepsisNaoyuki Matsuda, Seiji Yamamoto, Hiroki Yokoo, et al.
Molecular Pharmacology|January 18, 2005
WITHDRAWN: Up-Regulation of Insulin Receptor Substrate-1 and -2 by Neuronal Nicotinic Receptor-Induced Sequential Activation of Protein Kinase C-{alpha} and Extracellular Signal-Regulated Kinase (ERK): Enhancement of Insulin-Induced Phosphoinositide 3-Kinase and ERK Signaling Pathways in Adrenal Chromaffin CellsTakashi Sugano, Toshihiko Yanagita, Hiroki Yokoo, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|April 28, 2005
[Expression of insulin receptor and its signaling molecules: regulatory mechanisms in neuronal cells]Hiroki Yokoo, Takashi Sugano, Shinya Satoh, et al.
Journal of Neurochemistry|June 30, 2006
Enhancement of insulin-induced PI3K/Akt/GSK-3beta and ERK signaling by neuronal nicotinic receptor/PKC-alpha/ERK pathway: up-regulation of IRS-1/-2 mRNA and protein in adrenal chromaffin cellsTakashi Sugano, Toshihiko Yanagita, Hiroki Yokoo, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Journal of Pharmacological Sciences|November 24, 2004
Molecular mechanisms and drug development in aquaporin water channel diseases: aquaporins in the brainHideyuki Kobayashi, Toshihiko Yanagita, Hiroki Yokoo, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|June 14, 2002
[Regulation of brain microvessel function]Hideyuki Kobayashi, Hiroki Yokoo, Toshihiko Yanagita, et al.
Journal of Pharmacological Sciences|December 13, 2005
Lithium: potential therapeutics against acute brain injuries and chronic neurodegenerative diseasesAkihiko Wada, Hiroki Yokoo, Toshihiko Yanagita, et al.
Frontiers in Bioscience : a Journal and Virtual Library|February 24, 2004
Regulation of cell surface expression of voltage-dependent Nav1.7 sodium channels: mRNA stability and posttranscriptional control in adrenal chromaffin cellsAkihiko Wada, Toshihiko Yanagita, Hiroki Yokoo, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 13, 2003
Pathophysiological function of adrenomedullin and proadrenomedullin N-terminal peptides in adrenal chromaffin cellsHideyuki Kobayashi, Toshihiko Yanagita, Hiroki Yokoo, et al.
Journal of Pharmacological Sciences|October 8, 2005
New twist on neuronal insulin receptor signaling in health, disease, and therapeuticsAkihiko Wada, Hiroki Yokoo, Toshihiko Yanagita, et al.
Critical Care Medicine|August 27, 2009
Nuclear factor-kappaB decoy oligodeoxynucleotides ameliorate impaired glucose tolerance and insulin resistance in mice with cecal ligation and puncture-induced sepsisNaoyuki Matsuda, Seiji Yamamoto, Hiroki Yokoo, et al.
Molecular Pharmacology|January 18, 2005
WITHDRAWN: Up-Regulation of Insulin Receptor Substrate-1 and -2 by Neuronal Nicotinic Receptor-Induced Sequential Activation of Protein Kinase C-{alpha} and Extracellular Signal-Regulated Kinase (ERK): Enhancement of Insulin-Induced Phosphoinositide 3-Kinase and ERK Signaling Pathways in Adrenal Chromaffin CellsTakashi Sugano, Toshihiko Yanagita, Hiroki Yokoo, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|April 28, 2005
[Expression of insulin receptor and its signaling molecules: regulatory mechanisms in neuronal cells]Hiroki Yokoo, Takashi Sugano, Shinya Satoh, et al.
Journal of Neurochemistry|June 30, 2006
Enhancement of insulin-induced PI3K/Akt/GSK-3beta and ERK signaling by neuronal nicotinic receptor/PKC-alpha/ERK pathway: up-regulation of IRS-1/-2 mRNA and protein in adrenal chromaffin cellsTakashi Sugano, Toshihiko Yanagita, Hiroki Yokoo, et al.
Pageof 5